MED vs MKC: stock comparison and AI forecast
Medifast Inc (MED) and Mccormick & Co Inc (MKC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MED Medifast Inc
- Price
- $12.73 +0.3% · 6M
- Market Cap
- $142M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MKC Mccormick & Co Inc
- Market Cap
- $13.02B
- P/E Ratio
- 7.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MKC is 91.5 times larger than MED by market capitalization ($13.02B against $142M).
- MKC turns 19.4% of its revenue into net income, against -13.6% for MED.
- MKC carries 1.29 times debt per unit of equity, against 0.33 times for MED.
- MKC yields 3.90% in dividends and MED 0.51%.
- Both companies share the SEC industry classification Miscellaneous Food Preparations & Kindred Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MED | MKC |
|---|---|---|
| Market Cap | $142M | $13.02B |
| P/E Ratio | – | 7.90x |
| P/B Ratio | 0.79x | 1.86x |
| Dividend Yield | 0.51% | 3.90% |
| EPS | $-3.06 | $6.13 |
| Book Value/Share | $16.12 | $26.03 |
| Revenue/Share | $26.79 | $28.56 |
| FCF/Share | $-0.35 | $3.44 |
Profitability & Margins
| Metric | MED | MKC |
|---|---|---|
| ROE | -22.7% | 21.3% |
| ROA | -17.0% | 8.9% |
| ROIC | -17.6% | 8.4% |
| Gross Margin | 69.2% | 39.1% |
| Operating Margin | -11.6% | 13.4% |
| Net Margin | -13.6% | 19.4% |
| EBT Margin | -9.7% | 11.4% |
| Tax Rate | -40.1% | 25.9% |
Financial Health
| Metric | MED | MKC |
|---|---|---|
| Current Ratio | 4.82x | 0.66x |
| Quick Ratio | 4.32x | 0.49x |
| D/E Ratio | 0.33x | 1.29x |
| Financial Leverage | 1.33x | 2.38x |
| Interest Coverage | 585.2x | 3.2x |
| Working Capital | $160M | -$1.52B |
Cash Flow
| Metric | MED | MKC |
|---|---|---|
| Operating Cash Flow | -$30K | $1.14B |
| Free Cash Flow | -$4M | $926M |
| Capital Spending | -$4M | -$215M |
| OCF Growth YoY | -100.4% | 29.8% |
| FCF Growth YoY | -698.9% | 41.3% |
| FCF/Sales | -1.3% | 12.1% |
| CapEx/Sales | 1.3% | 2.8% |
Operational Efficiency
| Metric | MED | MKC |
|---|---|---|
| Asset Turnover | 1.25x | 0.46x |
| Receivables Turnover | – | 9.2x |
| Inventory Turnover | 4.3x | 6.5x |
| Fixed Assets Turnover | 22.6x | 5.0x |
| Days Sales Outstanding | – | 39 days |
| Days Inventory | 84 days | 56 days |
Income Statement
| Metric | MED | MKC |
|---|---|---|
| Total Revenue | $300M | $7.69B |
| Operating Income | -$35M | $1.03B |
| Net Income | -$41M | $1.49B |
| SG&A Expense | $242M | $1.74B |
| Cost of Goods Sold | $92M | $4.68B |
Dividend & Shareholder Information
| Metric | MED | MKC |
|---|---|---|
| Dividends Per Share | $0.07 | $1.89 |
| Payout Ratio | – | 30.8% |
| Shares Outstanding | 11M | 269M |
| Net Income Growth | -16639.3% | 91.6% |
| EPS Growth | – | 111.4% |
MED vs MKC: stock comparison and AI forecast
Which is bigger, MED or MKC?
MKC is 91.5 times larger than MED by market capitalization ($13.02B against $142M).
Which one does Intratio's AI model rank higher, MED or MKC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.